Neuropeptide Y is a signalling molecule that regulates stress and appetite. How does it affect weight gain and obesity? Learn more here.
Neuropeptides are small proteins used to transmit signals in the nervous system, and neuropeptide Y (NPY) is one of the most abundant of these, along with peptide YY (PYY) and pancreatic polypeptide (PP) [R].
NPY plays a role in appetite regulation, energy balance, sleep rhythms, cognition, and stress reduction. Because of its wide-ranging functions, NPY is found throughout many different parts of the brain [R, R].
Researchers also believe that NPY is critical for communication between the beneficial gut flora and the brain. It may help orchestrate our bodies’ immune reactions or tolerance to different species of gut bacteria, and it has direct antimicrobial action against pathogens like E. coli [R].
However, in the study of obesity and weight loss, the most important functions of NPY have to do with stress and appetite.
Neuropeptide Y (NPY) is a signalling protein that helps regulate appetite, energy balance, sleep, brain function, and stress.
Stress Eating & Fat Deposition
There are two major mechanisms by which elevated NPY may promote weight gain: by promoting stress eating and by directly stimulating the production of fat tissue.
NPY represents a link between stress and food intake, where a stress-induced increase in NPY may cause so-called “stress eating” [R].
Animal research suggests that NPY can reduce feelings of stress and anxiety. It is released during stressful periods and events, perhaps to counteract some of the negative physiological consequences of stress [R, R].
NPY counteracts stress in many ways, including by stimulating appetite and food intake. It may do this by decreasing the brain’s sensitivity to leptin, a hormone that causes feelings of fullness [R, R, R].
According to some researchers, NPY may also exert an influence on body weight by stimulating the creation of new fat cells, promoting fat storage, and helping blood vessels grow into the new fat tissues [R].
NPY increases in response to stress and may cause stress eating. It also seems to stimulate the deposition and growth of fat tissue.
Interactions with Ghrelin
Ghrelin, the “hunger hormone,” sends a signal that we don’t have enough energy, that we need to eat, and that we need to conserve our energy [R].
Ghrelin favors the accumulation of stomach fat, which in turn favors the formation of liver fat and increases the risk of developing insulin resistance [R, R].
Chronically high levels of ghrelin have been shown to increase food intake and promote fat storage in white and brown fat cells [R].
Researchers believe that ghrelin achieves some of these effects by increasing NPY [R].
Caution: NPY and Depression
As we’ve seen, higher NPY increases appetite and fat deposition, so it’s tempting to say that low NPY is good. However, NPY is important for preventing some of the worst effects of stress [R, R].
NPY is protective against anxiety and depression, and people with low-expression variants may be more susceptible to mental illness [R, R, R].
People with certain NPY variants may also be more susceptible to the physical effects of stress on the heart and nervous system [R].
As such, we don’t recommend going overboard trying to decrease NPY. If you have average or below-average expression variants of this gene, it’s best to check out the recommendations for other genes to help meet your weight loss goals.
Several variants in the NPY gene have been associated with weight gain, BMI, or obesity. At rs16139, the rare ‘C’ allele is associated with higher BMI; at rs5574, the uncommon ‘T’ allele is associated with obesity [R, R].
At rs16147, it is slightly more complicated. Here, either of the two homozygous genotypes (CC or TT) have been associated with relatively larger waist measurements compared to height, while the heterozygous genotype (CT) is associated with smaller waist to height ratio (WHR). WHR is often used as a measurement of fat deposition around the abdomen, so in this case, ‘CT’ would be considered the beneficial genotype [R].
However, other studies have found that the ‘TT’ genotype at rs16147 had the most potential for harm. It is possible that the study that found ‘CT’ to be beneficial was flawed in some way [R, R].
Diet
Dietary Fiber
In one study, people with detrimental NPY variants responded better to increased intake of soluble fibre than those without the potentially bad alleles. Participants with detrimental NPY variants experienced greater decreases in all measured markers of cholesterol, sugar metabolism, and heart health when they consumed fiber in the form of psyllium husk [R].
Fiber, both from foods and supplements, is known to increase satiety after a meal and decreases subsequent hunger. Studies suggest that an additional 14 g of fiber per day is associated with a 10% lower energy intake and weight loss [R].
How much is 14g? To put it into perspective, in the US, the average fiber intake is around 15 g/day which is only half of the recommended amount [R].
In a meta-analysis of 62 trials with over 3,800 people, soluble fiber modestly but significantly improved body weight and decreased waist circumference even without calorie restriction [R]!
Vegetables are rich in soluble fiber, which has been shown to cause weight loss in some studies. Fiber gets broken down by bacteria in the digestive tract to produce butyrate, which has weight loss effects in animals [R, R, R, R].
Low Energy Density Foods
People with detrimental NPY variants may respond better to and lose more weight from low-calorie diets [R].
Some human research suggests that eating the exact same food, except made in a soup instead of as solid food, makes people feel more satiated and eat significantly fewer calories [R, R].
The idea is that soup has a very low energy density; that is, you would have to eat much more soup by weight than other foods to get the same number of calories. In several human studies, dieters who ate less energy dense foods lost more weight than those who ate foods with a high energy density [R, R, R].
In one study, women who ate low energy density soup lost 50% more weight than women who ate an energy-dense snack [R].
People with detrimental NPY variants may respond better than others to dietary fiber (such as from psyllium husk) and low-calorie diets.
Supplements
Berberine
In rats, feeding a high-fat diet increases NPY levels; this increase was reversed in those given supplemental berberine [R].
Berberine is an alkaloid with potent metabolic effects. People use berberine as a supplement to support weight control and glucose metabolism.
Berberine supplementation reduced BMI and enhanced leptin sensitivity in 37 patients with metabolic syndrome. In another study, it caused an average weight loss of 5 lbs (2.3 kg) and lowered blood lipids [R, R].
According to a 2020 review of human and animal studies, berberine might contribute to weight loss by improving gut microbiota and glucose and fat metabolism [R].
Berberine, a popular supplement for weight loss, decreased NPY in rats fed a high-fat diet.
EGCG
In rats, EGCG normalized NPY expression which had been dysregulated by a high-fat diet [R].
EGCG caused between 0.2 and 3.5 kg of weight loss in limited human studies. Green tea, meanwhile, is hypothesized to make us burn more calories, even at rest. In most studies, this amounts to a modest 3-4% increase in energy, though some studies have shown an increase as high as 8%. For a 2,000 calorie diet, 3-4% amounts to an additional 60-80 calories per day [R, R, R, R, R, R].
In one study of 60 obese individuals, the group taking green tea extract lost 7.3lbs and burned 183 more calories per day (on average) after 3 months [R, R].
According to a review of 11 studies, green tea extract or EGCG can slightly improve weight loss and maintenance. However, a Cochrane database review of 14 studies regarded the change in weight as nonsignificant in most studies, so the evidence is inconclusive [R, R].
The majority of weight loss trials used special extracts with higher concentrations of active ingredients (catechins and caffeine), compared with regular tea. Hence, it may be necessary to take an EGCG-rich green tea extract for beneficial effects [R].
EGCG, the most important active compound in green tea and a promising supplement for weight management programs, may help normalize NPY levels.
CLA
Conjugated linoleic acids (CLA) are poly-unsaturated fatty acids. In rats, CLA injected into the brain decreased expression of NPY. CLA can cross the blood-brain barrier, so this study may help explain CLA’s possible uses in weight management [R, R].
A study done in overweight Chinese subjects found that CLA supplementation (twice daily dissolved in milk) helped with weight loss over a 12-week period [R].
The supplementation was found to reduce body weight, reduce BMI, reduce total fat mass, and reduce fat percentage [R].
The treatment also reduced waist to hip ratio and reduced subcutaneous fat mass [R].
Studies have shown that CLAs decrease lipid storage by increasing the rate of fat breakdown in fat tissue [R].
It should be noted, though, that in a similar study, CLA supplementation did not prevent weight or fat regain in obese peoples after initial weight loss [R, R].
It should also be noted that some studies have found no association between CLA and weight loss [R, R, R].
Conjugated linoleic acids (CLA) directly decrease expression of NPY in the brain. Supplementation with CLA has produced some positive results in clinical weight loss trials.
Disclaimer
The information on this website has not been evaluated by the Food & Drug Administration or any other
official medical body. This information is presented for educational purposes only, and may not be used
to diagnose or treat any illness or disease.
Also keep in mind that the “Risk Score” presented in this post is based only on a select number of
SNPs, and therefore only represents a small portion of your total risk as an individual. Furthermore,
these analyses are based primarily on associational studies, which do not necessarily imply causation.
Finally, many other (non-genetic) factors can also play a significant role in the development of a
disease or health condition — therefore, carrying any of the risk-associated genotypes discussed in this
post does not necessarily mean you are at increased risk of developing a major health condition.
Always consult your doctor before acting on any information or recommendations discussed in this post —
especially if you are pregnant, nursing, taking medication, or have been officially diagnosed with a
medical condition.